Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01612780 · ClinicalTrials.gov registry record · NA

Trans-Nasal Maxillary Multi-Sinus Balloon Dilation Study

A NA study, sponsored by Entellus Medical.

Completed
Registry status
NA
Development phase
82
Enrollment target

NCT01612780 is a NA study that has completed, run by Entellus Medical. The registered enrollment target is 82 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01612780, a NA study, has completed, sponsored by Entellus Medical.

COMPLETED
Registry status
NA
Development phase
82 participants
Enrollment target

Study Summary

The purpose of this study is to show clinically meaningful improvement in symptom severity after transnasal balloon dilation of the maxillary sinus outflow tract with or without balloon dilation of the frontal or sphenoid sinuses.

Interventions

  • DEVICE XprESS Multi-Sinus Dilation Tool

Trial Details

FieldValue
Enrollment Target 82 participants
Start Date 2012-04
Est. Completion 2013-10
Phase NA

Sponsor

Entellus Medical

11 total trials

What the Registry Record Tells You About NCT01612780

The ClinicalTrials.gov registry entry for NCT01612780 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Entellus Medical, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which XprESS Multi-Sinus Dilation Tool is the first listed.

NCT01612780 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01612780 about?

NCT01612780 is a clinical study titled "Trans-Nasal Maxillary Multi-Sinus Balloon Dilation Study". The purpose of this study is to show clinically meaningful improvement in symptom severity after transnasal balloon dilation of the maxillary sinus outflow tract with or without balloon dilation of the frontal or sphenoid sinuses.

What is the current status of trial NCT01612780?

This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2012-04. Estimated completion is 2013-10.

What interventions are being tested in trial NCT01612780?

The interventions under investigation include: XprESS Multi-Sinus Dilation Tool (DEVICE).

Who is sponsoring clinical trial NCT01612780?

This trial is sponsored by Entellus Medical, which has 11 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.